颅内动脉粥样硬化的高分辨MRI成像研究
2019-09-02赵东旭梁柏靓孙鹏
赵东旭 梁柏靓 孙鹏

[摘要] 目的 研究颅内动脉粥样硬化的高分辨MRI成像。方法 研究对象为方便选取颅内动脉粥样硬化患者,例数50例,采用抽签分组方式对研究对象50例进行分组,患者收取时间在2018年1—12月,分为观察组(25例颅内动脉粥样硬化患者)、对照组(25例颅内动脉粥样硬化患者),分别实施高分辨MRI成像诊断和超声诊断,将两组患者的诊断研究详细记录。结果 观察组颅内动脉粥样硬化患者的检出率高于对照组患者检出率(χ2=7.02;P<0.05);误诊率4.00%以及漏诊率4.00%低于对照组患者;敏感性92.00%和特异性96.00%高于对照组患者(χ2=5.56、8.00;P<0.05)。结论 通过对颅内动脉粥样硬化患者实施高分辨MRI成像诊断后,能早期对患者病情进行判定,具有较高的检出率,能准确发现患者动脉狭窄情况,值得研究。
[关键词] 颅内动脉粥样硬化;高分辨MRI成像;研究
[中图分类号] R445.2 [文献标识码] A [文章编号] 1674-0742(2019)06(a)-0193-03
[Abstract] Objective To study the high resolution magnetic resonance imaging (HRMRI) of intracranial atherosclerosis. Methods A total of 50 patients with intracranial atherosclerosis were convenient selected from January to December 2018. They were divided into observation group (25 patients with intracranial atherosclerosis) and control group (25 patients with intracranial atherosclerosis) by drawing lots. The observation group received high resolution MRI imaging diagnosis, while the control group received ultrasound diagnosis. Diagnosis of the two groups were recorded in detail. Results The detection rate of patients with intracranial atherosclerosis in the observation group was higher than that in the control group (χ2=7.02; P<0.05). The rate of misdiagnosis was 4.00% and the rate of missed diagnosis was 4.00%, which was lower than that of the control group. Sensitivity was 92.00% and specificity was 96.00%, which were higher than those in the control group (χ2=5.56, 8.00; P<0.05). Conclusion After the diagnosis of intracranial atherosclerosis with high resolution MRI, the patient's condition can be judged at an early stage, with a high detection rate and accurate detection of arterial stenosis. It is worth studying.
[Key words] Intracranial atherosclerosis; High resolution MRI imaging; Research
卒中近年來发病率不断增加,具有较高的死亡率和致残率,而导致脑卒中的发病机制和病因具有多种,其中以颅内动脉粥样硬化较为常见[1]。而随着临床高分辨率磁共振不断发展,MRI信噪比和分辨率显著提高,现如今已经成为神经影像热点内容[2]。因此,该院对2018年1—12月收治的50例颅内动脉粥样硬化的高分辨MRI成像研究进行分析,现报道如下。
1 资料与方法
1.1 一般资料
研究对象为方便选取颅内动脉粥样硬化患者,例数50例,采用抽签分组方式对研究对象50例进行分组,分为观察组(25例颅内动脉粥样硬化患者)、对照组(25例颅内动脉粥样硬化患者)。
纳入标准:①所有患者和家属均知情同意研究,且经医院医学伦理委员会批准。②患者无认知障碍和精神障碍。③临床各项资料完善,且符合该次研究需求。④具有较高配合度。
排除标准:①伴有其他疾病,比如恶性肿瘤疾病、造血系统异常以及血液系统疾病。……
